Why the Indian rupee opened 20 paise weaker today?

Why the Indian rupee opened 20 paise weaker today?

Mumbai: Fresh capital flight cast its shadow on the rupee as the local unit lost 27 paise at 64.42 against the United States dollar in the beginning, with additional support showing up in the form of demand from importers and banks. Meanwhile, the benchmark BSE Sensex was trading lower by 161.38 points or 0.53 per cent at 30,497.39. The dollar wallowed near six-month lows against a basket of major currencies on Thursday as the United States political crisis appeared to deepen, threatening to ...

Boy in car thieves took later found dead

Boy in car thieves took later found dead

Officials said Kingston died from a gunshot wound while sitting in the backseat of the vehicle. 05/18/2017 11:31am One person of interest is in custody in connection with the kidnapping of Kingston Frazier and authorities are looking for a second person who is wanted for questioning, according to the Hinds County Sheriff's Department.

CESC announces business restructuring scheme

Under the recast arrangement, for every 10 shares held by a CESC Ltd shareholder, he or she would get five shares each of the generation and the distribution companies, six of the retail company at a face value of ₹5 and two of the "other ventures" entity.

Spot Check on Stock With Abnormal Activity Ambev S.A. (NYSE:ABEV)

In general, more thrust is placed on most recent actions by assigning higher weights to it than those assigned to past movements. Return on Investment measures the amount of return on an investment relative to the investment's cost. A moving average (MA) is a trend-following or lagging indicator because it is based on past prices. It takes the sum of all of the past closing prices over a specific time period and divides the result by the number of prices used in the calculation.

Alnylam Pharmaceuticals, Inc. (ALNY) Given Consensus Rating of

Alnylam Pharmaceuticals, Inc. (ALNY) Given Consensus Rating of "Buy" by Analysts

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. 7,525 were accumulated by Kidder Stephen W. Axa stated it has 0.02% in Alnylam Pharmaceuticals, Inc. JMP Securities maintained Alnylam Pharmaceuticals, Inc. ALNY's revenue has declined at an average annualized rate of about -10.6% during the past five years.